Litigation Details for Teijin Limited v. Aurobindo Pharma Ltd. (D. Del. 2017)
✉ Email this page to a colleague
Teijin Limited v. Aurobindo Pharma Ltd. (D. Del. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-09-15 |
Court | District Court, D. Delaware | Date Terminated | 2018-04-20 |
Cause | 35:271 Patent Infringement | Assigned To | Vacant Judgeship |
Jury Demand | None | Referred To | Mary Pat Thynge |
Patents | 6,225,474; 7,361,676; 8,372,872; 9,107,912 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Teijin Limited v. Aurobindo Pharma Ltd.
Details for Teijin Limited v. Aurobindo Pharma Ltd. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-09-15 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,225,474 B1; 7,361,676 B2; 8,372,872…2017 20 April 2018 1:17-cv-01314 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |